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OBJECTIVES Coronary stenting is the primary therapeutic option for percutaneous treatment of many
coronary lesions, after the risk of subacute stent thrombosis and bleeding complications has
been reduced by improved antithrombotic regimens and high pressure stent expansion.
BACKGROUND Direct stent implantation (without predilation) has been considered a promising new
technique that may reduce the procedure time, radiation exposure time and cost.
METHODS After having reviewed all cases of stent implantation from February to June 1998 (n 5 585),
185 (32%) of these patients were retrospectively considered candidates for direct stent
implantation without predilation, according to prespecified criteria (i.e., absence of severe
coronary calcifications and/or tortuosity of the lesion or the segment proximal to the lesion).
By operator preference, direct coronary stent implantation was actually attempted in 123
(21%) of the 585 patients (100 men, 60 6 10 years old) on 123 lesions. The impact of direct
stenting in terms of cost, procedure time, radiation exposure time and amount of contrast dye
used was assessed by comparing the two groups of patients who underwent single-vessel
stenting without (n 5 69) and with (n 5 46) predilation.
RESULTS Direct stenting was successful in 118 patients (96%). No acute or subacute complications
occurred in these patients. Procedure time, radiation exposure time and cost were significantly
lower in the group of patients who had single-vessel direct versus conventional stenting (45 6
31 vs. 64 6 46 min, 12 6 9 vs. 16 6 10 min and 1,305 6 363 vs. 2,210 6 803 Euro,
respectively; p , 0.05 for all).
CONCLUSIONS Direct stenting without predilation in selected lesions seems to be a safe and successful
procedure that provides a way to contain cost and to shorten radiation exposure time. (J Am
Coll Cardiol 1999;34:1910–5) © 1999 by the American College of Cardiology
Since the introduction of coronary stent implantation,
interventional cardiologists have been using stents in ever
increasing numbers (1). Improved long-term outcomes have
contributed to the increase in stent usage, compared with
balloon angioplasty, as demonstrated in two randomized
trials (2,3). Moreover, the risk of subacute stent thrombosis
and bleeding complications has been reduced by antithrom-
botic regimens and improved stent expansion (4). There are,
however, several concerns related to this dramatic rise in the
use of coronary stents—namely, the initial increase in cost
to the patients and health care providers (5,6). In addition,
in complex procedures there may be prolonged exposure
time to radiation for both patients and operators, as well as
an increase in the amount of contrast agent used (5).
The standard procedure recommended for stent implan-
tation includes standard balloon angioplasty (predilation)
followed by stent deployment. The availability of a low
profile stent delivery system allows simplification of this
procedure, avoiding the use of predilation. Direct coronary
stenting without predilation may be helpful in reducing
procedure time, cost and radiation exposure. To date, few
reports exist about the feasibility and the potential advan-
tages of direct coronary stenting (7–10). In the present study
we analyzed: 1) the percentage of patients eligible for direct
stenting in a single high volume center; 2) the feasibility of
direct stenting using the common commercially available
delivery system; 3) early results and complications of direct
stenting; 4) the impact of direct stenting on cost, procedure
time and radiation exposure time; and 5) the amount of
contrast dye used.
METHODS
Patient group. From February to July 1998, 585 patients
(806 lesions) underwent percutaneous transluminal coro-
nary angioplasty (PTCA) with stent implantation in our
institution. One-hundred eighty-five patients (32%) were
considered “candidates” for direct stenting without predila-
tion by two senior PTCA operators who independently
reviewed the coronary angiograms. Agreement occurred in
all patients but 10, for whom consensus was reached by
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consultation. Direct stenting was considered suitable in case
of 1) vessel $2.5 mm in diameter; 2) absence of severe
coronary calcifications; 3) absence of significant angulation
(bend .45°); and 4) absence of occlusions and bifurcation
lesions. One-hundred twenty-three (67%) of the 185 pa-
tients actually underwent direct stenting; these patients
represent our total group of direct stenting. The remaining
62 patients (33%), although considered candidates for direct
stenting, actually underwent traditional stent implantation
with predilation because of operator preference.
Sixty-nine of the 123 patients underwent only single-
vessel direct stenting, whereas the remaining 54 had mul-
tivessel coronary angioplasty (i.e., single-vessel direct stent-
ing plus “conventional” coronary angioplasty and/or stenting
on other[s] vessel[s]). This means that the 123 patients
(total group) can be classified into the group with single-
vessel disease traditionally best suitable for direct stenting
(group 1) and into the group with multivessel disease who
underwent direct stenting on one lesion and additional
procedures on the others. The clinical characteristics of the
total group (n 5 123) who underwent direct stenting (total
group) and of the subgroup who had only single-vessel
direct stenting (group 1) are summarized in the Table 1.
Table 2 outlines the angiographic and procedural charac-
teristics.
All patients received a low intraarterial bolus dose of
unfractionated heparin (70 to 80 UI/kg). An Extra Back-up
guiding catheter (Cordis, Miami, Florida) was generally
used to cannulate the left anterior descending coronary
artery and the left circumflex artery, and a right Judkins or
left Amplatz catheter was used for the right coronary artery.
After crossing the lesion with a soft guide wire, the stent
was advanced over the guide wire and positioned properly.
The passage of the stent to the desired position at the lesion
Abbreviations and Acronyms
MACE 5 major adverse cardiac events
PTCA 5 percutaneous transluminal coronary
angioplasty
Table 1. Clinical Characteristics of Total Study Group
(n 5 123) and of Patients Who Underwent Single-Vessel









Age (yrs) 60 6 10 61 6 12 62 6 10
Male 100 (81%) 60 (87%) 40 (87%)
Previous MI 59 (48%) 30 (43%) 21 (45%)
LVEF (%) 55 6 16 60 6 10* 61 6 17*
Unstable
angina
40 (32%) 19 (34%) 15 (33%)
Hypertension 58 (47%) 36 (47%) 19 (41%)*†
Diabetes
mellitus
35 (28%) 21 (27%) 4 (9%)*†
Coronary artery
disease
Single-vessel 67 (54%) 40 (58%) 27 (59%)
Double-
vessel
20 (16%) 10 (14.5%) 7 (15%)
Triple-vessel 36 (29%) 19 (27.5%) 12 (26%)
*p , 0.05 vs. total group. †p , 0.05 vs. group 1. Data are presented as the mean
value 6 SD or number (%) of patients.
LVEF 5 left ventricular ejection fraction; MI 5 myocardial infarction.
Table 2. Angiographic and Procedural Characteristics of Total
Study Group (n 5 123) and of Patients Who Underwent
Single-Vessel Direct (Group 1) and Single-Vessel Traditional









LAD 38 (31%) 24 (35%) 17 (37%)
LCx 18 (15%) 16 (23%) 11 (23%)
RCA 46 (37%) 20 (29%) 12 (26%)
Diagonal 2 (1.5%) 2 (3%) 2 (4%)
Obtuse marginal 13 (10.5%) 4 (6%) 2 (4%)
Vein graft 6 (5%) 3 (4%) 1 (1%)
LMCA 0 0 1 (2%)
Lesion site
Ostial 1 (1%) 0 0
Proximal 57 (46%) 35 (50%) 22 (48%)
Midvessel 51 (41.5%) 20 (29%) 14 (30%)
Distal 14 (11.5%) 14 (20%) 10 (21.7%)
Lesion type*
A 8 (6.5%) 6 (9%) 4 (9%)
B1 60 (49%) 38 (55%) 26 (56%)
B2 35 (28.5%) 15 (22%) 9 (20%)
C 20 (16%) 10 (14%) 7 (15%)
Thrombus 9 (7%) 3 (4%) 6 (13%)
Reference diameter
(mm)
3.1 6 0.4 3.1 6 0.6 3.0 6 0.4
Diameter stenosis
(%)
Before 77 6 15 71 6 14 74 6 14
After 2 6 6 2 6 9 23 6 6
MLD (mm)
Before 0.9 6 0.4 0.9 6 0.4 0.9 6 0.4
After 3.2 6 0.3 3.3 6 0.3 3.1 6 0.5
Lesion length
(mm)
12 6 7 12 6 4 15 6 9
Balloon-vessel ratio 1.16 6 0.2 1.16 6 0.2 1.16 6 0.2
Maximal inflation
pressure (atm)
14 6 2 13 6 2 15 6 4†
*Modified American Heart Association/American College of Cardiology criteria.
†p , 0.05 vs. group 1. Data are presented as the mean value 6 SD or number (%)
of patients.
LAD 5 left anterior descending artery; LCx 5 left circumflex artery; LMCA 5
left main coronary artery; MLD 5 minimal lumen diameter; RCA 5 right coronary
artery.
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site was attempted with moderate push, and if necessary
(while possible and safe), with deep intubation of the
guiding catheter. If this approach was not successful, the
lesion was dilated with a standard low profile angioplasty
balloon before stenting. After stent implantation, angio-
graphic optimization was performed by using high pressure
balloon dilation to achieve a good angiographic result with
,20% residual stenosis by visual estimate. If the angio-
graphic assessment of the lesion demonstrated incomplete
expansion of the stent or presence of residual stenosis
.20%, or both, a short balloon capable of high pressures
was used for further inflation. Patients received intracoro-
nary isosorbide dinitrate (1 to 3 mg) before the initial and
final angiograms to achieve maximal vasodilation. The
stents implanted with a direct technique without predilation
included the NIR stent (46%) (SciMed, Boston Scientific,
Maple Grove, Minnesota), the ACS Multi-Link Duet
(36%) (Guidant Inc., Temecula, California), the AVE GFX
(9%) (Applied Vascular Engineering Inc., Santa Rosa,
California), the Palmaz-Schatz (1.5%) and the CrossFlex
(6.5%) stents (Johnson & Johnson Interventional System
Co, Warren, New Jersey) and the Crown stent (1%)
(Cordis). In particular, the NIR stent was mounted on a
Activa balloon (crossing profile 1.08 mm), and the ACS
Multi-Link delivery system had a crossing profile of
1.19 mm.
In all patients, indications for stenting were elective,
because the operator elected to use stenting before starting
the procedure. Angiographic measurements were performed
as previously described with an automated computer-based
system by experienced angiographers not involved in the
stenting procedure (4). A clinically significant lesion was
defined as stenosis with at least $70% reduction of the
reference vessel diameter as assessed visually. Lesions were
characterized according to the modified American College
of Cardiology/American Heart Association classification
(11). Thrombus was defined as a filling defect seen in
multiple projections surrounded by contrast medium. Left
ventricular ejection fraction was measured by the ventricular
angiogram with the area–length ellipsoid method. Any
in-hospital major adverse cardiac event (MACE) (i.e.,
death, Q and non–Q wave myocardial infarction, coronary
artery bypass graft surgery or PTCA) was assessed. Non–Q
wave myocardial infarction was defined as chest pain or ST
segment or T wave abnormalities, transient or sustained,
associated with an increase of total creatine kinase two times
or more above normal values without any new pathologic Q
wave. Cardiac enzymes were measured in case of 1) tran-
sient or permanent vessel or side branch occlusion during
the procedure; 2) prolonged ($15 min) chest pain after a
successful procedure; and 3) electrocardiographic changes
with or without chest pain. Clinical follow-up was per-
formed at 1 month by telephone contact to the patients or
the referring physician.
Potential advantages of direct coronary stenting. To
define the potential impact of direct coronary stenting on
cost, procedure time, radiation exposure time and the
amount of contrast media used, we compared the patients
with single-vessel stenting who actually had direct stenting
(group 1, n 5 69) with the patients who were considered
“candidates” (but not actually underwent) for direct stenting
(group 2, n 5 46). These comparisons excluded all patients
with multivessel disease who were traditionally less suitable
for direct stenting. The clinical, angiographic and proce-
dural characteristics of the two groups are summarized in
Tables 1 and 2. Cardiac catheterization laboratory utiliza-
tion and costs were estimated as the costs of all supplies and
personnel utilized in each procedure. Procedure cost, per se,
was estimated by accounting for resource utilization, includ-
ing angioplasty balloons, devices (i.e., stents) guiding
catheters, guide wires and contrast dye (all recorded for each
procedure). Balloons employed were calculated by consid-
ering the balloon of the stent delivery system as one. The
cost of each item was determined by using actual manufac-
turer’s charges to the hospital during the financial year 1997.
Cardiac catheterization laboratory cost included additional
equipment costs, laboratory room costs and personal costs,
estimated on the basis of an average cost per procedure and
adjusted for actual procedure duration. Cardiac catheteriza-
tion laboratory cost in our institution was estimated ’1,015
Euro/h during the financial year 1997. The total procedure
cost (1 Euro 5 0.93 U.S. dollar) was assessed as the sum of
procedure cost, per se, and cardiac catheterization laboratory
cost.
Statistical analysis. Continuous variables are given as the
mean value 6 SD. Probability values ,0.05 were consid-
ered significant. The Student t test and chi-square test were
performed to compare continuous and categorical variables,
respectively. Data were analyzed with SPSS for Windows
6.1.
RESULTS
Feasibility of direct stenting. Direct stent deployment
without predilation was successfully performed in 118 pa-
tients (96%). In the remaining five patients (4%), the stent
could be successfully withdrawn (without stent loss or
damage), and after predilation the same stent was success-
fully deployed. A downward occlusive coronary dissection
occurred in two patients; both were treated with prolonged
balloon inflation and additional stenting. In no patient did
stent loss or failed expansion of the stent during deployment
occur. Primary success was therefore 94%; overall procedural
success was 96%; and angiographic success was attained in
all patients. There were no in-hospital deaths, myocardial
infarctions or emergency bypass surgeries. During the first
month of follow-up, no patients had subacute stent throm-
bosis or MACE.
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Potential advantages of direct stent implantation. Tables
1 and 2 outline the clinical, angiographic and procedural
characteristics of patients who underwent single-vessel
stenting without predilation (n 5 69, group 1) and with
predilation (n 5 46, group 2). Hypertension and diabetes
mellitus were more frequent in group 1. Direct stenting was
successful in all 69 patients of group 1; thus, no additional
stent and/or balloon was necessary (procedural success
100%). Angiographic success was achieved in all patients in
the two groups. Residual stenosis and minimal lumen
diameter after stent deployment was not statistically differ-
ent between the two groups. Furthermore, no residual
dissection was present in the two groups. The procedure
cost, procedure time, radiation exposure time and amount of
contrast dye used in the 69 patients with successful single-
vessel direct stent deployment (direct stenting group) and in
the 46 patients with “traditional” stenting with predilation
are summarized in Table 3. Of note, all these variables were
significantly lower in group 1. In particular, the average
number of balloons used was 1.7 for traditional stenting and
1.0 for direct stenting (p , 0.001). No patients in the two
groups experienced acute and subacute stent thrombosis or
MACE one month after the procedure.
DISCUSSION
Coronary stenting has revolutionized the field of interven-
tional cardiology, which previously relied on balloon dila-
tion in the majority of patients. This rapid acceptance of
coronary stenting has been due to two main factors. First,
large randomized multicenter trials have shown that stent-
ing has a lower restenosis rate and a better long-term clinical
outcome than coronary balloon angioplasty in de novo or
restenotic lesions (2,3). Furthermore, smaller nonrandom-
ized studies have also demonstrated that stenting can
improve primary and long-term success in lesions with high
recurrence rates after balloon angioplasty, such as stenosis in
vein bypass grafts, aorto-ostial stenosis and chronic total
occlusion (2,3). Second, stent thrombosis, bleeding and
vascular complication are no longer a major concern because
of the improvements in deployment technique and in
antiplatelet therapy (4,12). Elective coronary stenting be-
came the most frequent indication for coronary stenting,
followed by bailout stenting and stenting for an inadequate
result (13). There are, however, several concerns related to
this dramatic rise in the use of coronary stents—namely, the
initial increase in cost to the patients and health care
providers (5,6). In addition, in complex procedures there
may be prolonged exposure time to radiation for both
patients and operators, as well as an increase in the amount
of contrast media used (6–14).
Direct coronary stenting. Direct coronary stenting with-
out predilation may be helpful in reducing procedure times,
costs and radiation exposure without increasing the risk to
patients. Furthermore, in animal models, when a stent is
placed without antecedent balloon denudation, sufficient
endothelium remains within the stented segment to allow
repopulation with a much reduced requirement for endo-
thelial proliferation and migration (15). It is therefore
hypothesized that if some endothelium is present in athero-
sclerotic vessels, a stent used without predilation may
provide a means for dilating arteries while avoiding com-
plete endothelial denudation (16). In the present study we
found that direct stenting was considered suitable (by two
independent invasive cardiologists) in 32% of patients who
underwent coronary stent implantation. Although this is a
retrospective analysis, and selection and observer-related
biases should be taken into account, to our knowledge, this
is the first study to quantitatively define the potential
suitability of direct stenting.
The main finding that emerges from this single-center
experience is that direct coronary stenting without predila-
tion is a feasible and safe new therapeutic approach. In our
experience, it was successful in 96% of the patients. Of note,
complications occurred rarely; in fact, no patient had stent
loss, whereas dissections after the initial stent deployment
were observed in ,2% of successful direct coronary stenting.
Thus, the lack of predilation of the stenotic segment in
direct coronary stenting does not seem to predispose to this
complication, and may actually decrease its occurrence.
Recently, Figulla et al. (7) reported a direct coronary
stenting success rate of 80% by using a rapid exchange
balloon catheter. In the present study we reported our
experience of direct coronary stenting using some of the
commonly available very low profile stents. In particular, we
mostly used the NIR stent mounted on a Activa balloon
catheter (crossing profile 1.08 mm) and the ACS Multi-
Link Duet delivery system (crossing profile 1.19 mm) stent.
Delivery system crossing profile ranged from 1.08 mm (NIR
on Viva Primo) to 1.27 mm (AVE GFX II). The minimal
lumen diameter of the target lesion was 0.9 6 0.5 mm. The
average percent stenosis was 77 6 15%, in the same range as
that reported by Figulla et al. (7).
Potential advantages of direct coronary stenting. Treat-
ment costs for coronary stenting are significantly higher
than those for conventional angioplasty (5,6). Conse-
Table 3. Comparison Between the Group That Underwent
Direct (Group 1) and the Group That Underwent Traditional





Procedure time (min) 45 6 21 64 6 46*
Radiation exposure time (min) 12 6 9 16 6 10*
Contrast dye used (ml) 183 6 96 255 6 110*
Cost (Euro)
Balloons and devices 697 6 50 1,128 6 25*
Catheterization and laboratory/h 608 6 338 1,082 6 778*
Total 1,305 6 363 2,210 6 803*
*p , 0.05. Data are presented as the mean value 6 SD.
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quently, several investigators have cautioned that wide-
spread application of these procedures might have a delete-
rious impact on national health care expenditures, thus
tempering the general level of enthusiasm for these tech-
nique (5,6). Although any evaluation of the cost-
effectiveness of any therapeutic strategy must take into
account both the costs and benefits of the treatment relative
to its alternative, a favorable cost-benefit ratio would be met
by coming close to the use of one stent and one balloon per
patient. In this contest, one rational approach is the use of
the same balloon for predilation and subsequent stent
expansion.
According to Figulla et al. (7), in the present study we
found that direct stenting without predilation significantly
reduced procedure time and radiation exposure as compared
with conventional stent implantation with predilation. In
particular, procedure time was decreased by 30%, radiation
exposure by 25%, contrast agent use by 28% and cost by
41%. Procedural variables such as radiation exposure time
are difficult to compare among different institutions. In fact,
Schatz et al. (17), who compared radiation exposure in
different interventional techniques, gave exposure times for
conventional balloon angioplasty and stenting between 24
and 29 min. Furthermore, Figulla et al. (7) reported a
radiation exposure time of 8.7 6 5.1 min in direct stenting
and 12.6 6 7.6 min in conventional stent implantation.
Other potential advantages of direct stenting without
predilation might be represented by the reduction of isch-
emic time, which could be clinically relevant in specific
patient subgroups (i.e., patients with severe left ventricular
dysfunction and patients with left main coronary artery
disease). In these patients, primary stenting might allow
shortening of ischemic time and improving clinical out-
come. Nevertheless, direct stenting might reduce the resten-
osis rate, as was pointed out in two experimental studies
(15,16). Prospective randomized studies are currently used
to confirm both the short-term and possibly long-term
benefits of this approach.
Study limitations. The major limitation of the present
study is that it is a nonrandomized study. The criteria for
selecting patients suitable for primary stenting were subjec-
tive; therefore, an intrinsic bias is present. All of the 62
patients who were considered suitable for direct stenting
actually underwent the “conventional” procedure because of
operator preference. Direct stent implantation without
predilation is more demanding than the conventional pro-
cedure, and more experience is required with the interven-
tional decision strategy than with the conventional proce-
dure. A potential limitation of the direct stenting approach
is the occasional event of incomplete balloons and stent
expansion in a calcified lesion, which could have been
pretreated by rotational atherectomy. We did not encounter
this problem because we excluded lesions with severe
calcification and because our study group was quite small.
Another limitation could be the smaller lumen cross-
sectional area found in direct stenting as compared with
traditional stenting owing to less aggressive predilation and
postdilation. We cannot address this issue because of the
fact that no intravascular ultrasound evaluation was system-
atically performed. From a conceptual point of view, it
should be kept in mind that performance of direct stenting
does not preclude evaluation of the final result by intravas-
cular ultrasound and subsequent aggressive postdilation, if
necessary.
Conclusions. In this study we found that direct stenting
without predilation in selected lesions seems to be a safe and
feasible procedure that provides a way to contain cost and
shorten radiation exposure time. This approach may be
performed using the commonly available stents and delivery
systems. Other studies are needed to verify the impact of
direct stenting on restenosis rates and long-term clinical
outcomes.
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